» Articles » PMID: 26277079

Body Mass Index As a Prognostic Factor in Resected Lung Cancer: Obesity or Underweight, Which Is the Risk Factor?

Overview
Date 2015 Aug 17
PMID 26277079
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In general, obesity is thought to be associated with increased surgical mortality and morbidity. On the other hand, low body mass index (BMI) has recently been reported as a poor prognostic factor for surgical candidates. This study investigated the effect of BMI on lung surgery.

Methods: A retrospective study was conducted on 1,518 consecutive patients who had malignant pulmonary tumors resected between February 2008 and March 2013. BMI was used to classify patients according to the World Health Organization definition: BMI < 18.5: underweight (UW); BMI 18.5 to <25: normal weight (NW); BMI 25 to <30: overweight (OW); and BMI ≥ 30: obese (OB). We defined surgical resection-related mortality as any patient who died within 90 days after resection or while in the hospital. We analyzed morbidity and surgical resection-related mortality, and logistic regression analysis was used to identify predictors for surgical resection-related mortality.

Results: Among the four groups, the incidence of cerebrovascular complications was 1.5% in UW, 0.4% in NW, 0% in OW, and 0% in OB, and that of pulmonary complications was 13.1% in UW, 8.4% in NW, 7.3% in OW, and 7.6% in OB. Surgical resection-related mortality was 2.9% in UW, 0.6% in NW, 1.7% in OW, and 0% in OB. Multivariate analysis revealed underweight, diffusing capacity of the lung for carbon monoxide, and male sex as the significant predictors.

Conclusions: In this study, low BMI was an independent risk factor for mortality, and the incidence of cerebrovascular and pulmonary complications tended to be higher in patients with low BMI than in obese patients. Underweight patients should be closely monitored following pulmonary resection.

Citing Articles

Incidence and risk factors of pulmonary complications after lung cancer surgery: A systematic review and meta-analysis.

Deng T, Song J, Tuo J, Wang Y, Li J, Suen L Heliyon. 2024; 10(12):e32821.

PMID: 38975138 PMC: 11226845. DOI: 10.1016/j.heliyon.2024.e32821.


Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients-A Retrospective Observational Study.

Siringo M, Gentile G, Caponnetto S, Sperduti I, Santini D, Cortesi E Cancers (Basel). 2023; 15(13).

PMID: 37444532 PMC: 10340506. DOI: 10.3390/cancers15133422.


Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies.

Nitsche L, Mukherjee S, Cheruvu K, Krabak C, Rachala R, Ratnakaram K Cancers (Basel). 2022; 14(6).

PMID: 35326592 PMC: 8946288. DOI: 10.3390/cancers14061440.


Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma.

Lee J, Yoon Y, Kim H, Cha M, Kim J, Kim K J Cachexia Sarcopenia Muscle. 2022; 13(2):1076-1086.

PMID: 35212195 PMC: 8978026. DOI: 10.1002/jcsm.12956.


Risk factors for pulmonary complications after neoadjuvant chemoradiotherapy followed by surgery for non-small cell lung cancer.

Kim H, Yu W, Lee C, Lee J, Kim D, Park S Thorac Cancer. 2021; 13(3):361-368.

PMID: 34905807 PMC: 8807251. DOI: 10.1111/1759-7714.14263.